Literature DB >> 3109929

The effect of recombinant human tumour necrosis factor on growth and macromolecular synthesis of human epithelial cells.

G B Dealtry, M S Naylor, W Fiers, F R Balkwill.   

Abstract

We have studied the effect of recombinant human tumour necrosis factor (rHuTNF) on growth and macromolecular synthesis in a range of normal and transformed epithelial cell types. Tumour necrosis factor did not affect the growth of normal human mammary epithelial cells, but its growth-inhibitory action on the SV40-transformed human mammary epithelial cell line HBL-100 increased with passage number in association with a progression of malignant phenotype. However, of two lines derived from nude mouse tumours of HBL-100 lines, one, HBLT-12, did not respond to rHuTNF, and the other, HBLT-11 showed some growth stimulation by high dose rHuTNF. Macromolecular synthesis in HBLT-11 was not affected by rHuTNF. The breast cancer cell lines MCF-7 and BT20 were sensitive to the cytotoxic effects of rHuTNF. In MCF-7 a gradual decrease in RNA and DNA synthesis occurred over 48 h, ending with an accumulation of cells in S and G2 phase of the cell cycle and cell death. The addition of alpha- or gamma-interferon increased, but did not accelerate the cytotoxicity of rHuTNF.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109929     DOI: 10.1016/0014-4827(87)90318-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells.

Authors:  A Andoh; Y Fujiyama; K Sumiyoshi; H Sakumoto; H Okabe; T Bamba
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

2.  Tumor necrosis factor in benign and malign tissue of the kidney.

Authors:  K H Bichler; S Kleinknecht; H J Nelde; W L Strohmaier
Journal:  Urol Res       Date:  1991

Review 3.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

4.  Cytokine effects in a human colonic goblet cell line. Cellular damage and its partial prevention by 5 aminosalicylic acid.

Authors:  A Jarry; F Muzeau; C Laboisse
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

Review 5.  Systemic use of tumor necrosis factor alpha as an anticancer agent.

Authors:  Nicholas J Roberts; Shibin Zhou; Luis A Diaz; Matthias Holdhoff
Journal:  Oncotarget       Date:  2011-10

6.  In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.

Authors:  A H van der Veen; A L Seynhaeve; J Breurs; P T Nooijen; R L Marquet; A M Eggermont
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

7.  Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

Authors:  Alfiah Noor; Ijeoma Adaku Umelo; Peter Kronenberger; Philippe Giron; Elly De Vlieghere; Olivier De Wever; Erik Teugels; Jacques De Grève
Journal:  Oncotarget       Date:  2018-06-19

8.  Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction.

Authors:  L Pusztai; C E Lewis; J O McGee
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.